Home/Filings/4/0001209191-10-036969
4//SEC Filing

Mermelstein Fred H 4

Accession 0001209191-10-036969

CIK 0000050710other

Filed

Jul 1, 8:00 PM ET

Accepted

Jul 2, 3:17 PM ET

Size

27.7 KB

Accession

0001209191-10-036969

Insider Transaction Report

Form 4
Period: 2010-06-30
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0275,0000 total
    Exercise: $4.05Exp: 2016-03-08Common Stock (75,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0251,7420 total
    Exercise: $5.36From: 2004-12-06Exp: 2012-02-25Common Stock (51,742 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-02254,6030 total
    Exercise: $1.50From: 2004-12-06Exp: 2013-08-22Common Stock (254,603 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-02125,0000 total
    Exercise: $2.70From: 2005-04-12Exp: 2015-04-12Common Stock (125,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0270,0000 total
    Exercise: $4.98Exp: 2017-01-03Common Stock (70,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-02103,4850 total
    Exercise: $3.87From: 2004-12-06Exp: 2010-11-14Common Stock (103,485 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0250,9210 total
    Exercise: $3.87From: 2004-12-06Exp: 2012-09-18Common Stock (50,921 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-02127,3010 total
    Exercise: $1.96From: 2004-12-06Exp: 2013-12-15Common Stock (127,301 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0270,0000 total
    Exercise: $3.53Exp: 2018-01-09Common Stock (70,000 underlying)
  • Disposition from Tender

    Common Stock

    2010-06-30$2.20/sh577,316$1,270,0950 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2010-07-0275,0000 total
    Exercise: $2.70Exp: 2015-04-12Common Stock (75,000 underlying)
Footnotes (9)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated April 17, 2010, by and among Hospira, Inc., Discus Acquisition Corporation ("Purchaser") and Javelin Pharmaceuticals, Inc. (the "Company"), Purchaser merged with and into the Company on July 2, 2010 (the "Merger"). These shares, which were outstanding immediately prior to the effective time of the Merger (the "Effective Time"), were immediately canceled and converted at the effective time of the Merger into the right to receive cash consideration equal to $2.20 per share.
  • [F2]These options, which were outstanding, unexercised and fully vested immediately prior to the Effective Time were immediately canceled and terminated.
  • [F3]These options, which were outstanding, unexercised and fully vested immediately prior to the Effective Time were immediately canceled, terminated and converted into the right to receive a cash payment of $178,222.10, representing (a) the difference between the exercise price of the option and the merger consideration of $2.20 per share multiplied by (b) the number of shares subject to the option.
  • [F4]These options, which were outstanding, unexercised and fully vested immediately prior to the Effective Time were immediately canceled, terminated and converted into the right to receive a cash payment of $30,552.24, representing (a) the difference between the exercise price of the option and the merger consideration of $2.20 per share multiplied by (b) the number of shares subject to the option.
  • [F5]One-third of the shares were exercisable as of April 12, 2006, April 12, 2007 and April 12, 2008.
  • [F6]One-third of the shares were exercisable as of March 8, 2007, March 8, 2008 and March 8, 2009.
  • [F7]The vesting of these options were in three equal annual installments beginning January 5, 2008.
  • [F8]The vesting of these options were in three equal annual installments beginning January 9, 2009.
  • [F9]These options, which were outstanding and unexercised immediately prior to the Effective Time were immediately canceled and terminated.

Issuer

JAVELIN PHARMACEUTICALS, INC

CIK 0000050710

Entity typeother

Related Parties

1
  • filerCIK 0001311357

Filing Metadata

Form type
4
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 3:17 PM ET
Size
27.7 KB